These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 2177397)
1. [Computer study of pathologic factors influencing survival in colorectal carcinoma--a multivariant stepwise discriminant analysis]. Zhou W Zhonghua Zhong Liu Za Zhi; 1990 Sep; 12(5):354-6. PubMed ID: 2177397 [TBL] [Abstract][Full Text] [Related]
2. Histopathological grade, mucinous differentiation and DNA ploidy in relation to prognosis in colorectal carcinoma. Purdie CA; Piris J Histopathology; 2000 Feb; 36(2):121-6. PubMed ID: 10672056 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934 [TBL] [Abstract][Full Text] [Related]
4. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma. Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299 [TBL] [Abstract][Full Text] [Related]
6. Predictors of surgery outcome for colorectal carcinoma in the United Arab Emirates. el-Ghazawy IM; Bener A; Saad el-Din SS; Abou Azab I; Siddiqui M East Mediterr Health J; 2001; 7(1-2):221-8. PubMed ID: 12596973 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related]
8. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate. Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761 [TBL] [Abstract][Full Text] [Related]
10. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression. Martín R; Nieto S; Santamaría L Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906 [TBL] [Abstract][Full Text] [Related]
11. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma. Mäkelä J; Kiviniemi H; Laitinen S Hepatogastroenterology; 2002; 49(46):971-5. PubMed ID: 12143256 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of multiple prognostic factors in colorectal cancer]. Wang S; Yu YX; Zhang JQ Zhonghua Wai Ke Za Zhi; 1994 May; 32(5):289-91. PubMed ID: 7842945 [TBL] [Abstract][Full Text] [Related]
14. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers. Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623 [TBL] [Abstract][Full Text] [Related]
15. [Morphometric analysis of colorectal carcinoma and its clinical significance]. Zhou WG Zhonghua Bing Li Xue Za Zhi; 1990 Mar; 19(1):61-3. PubMed ID: 2166628 [TBL] [Abstract][Full Text] [Related]
16. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation. Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804 [TBL] [Abstract][Full Text] [Related]
17. Comparison of classic and quantitative prognostic factors in colorectal cancer. Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274 [TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer. Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694 [TBL] [Abstract][Full Text] [Related]
19. Incidence and survival of mucinous adenocarcinoma of the colorectum: a population-based study from an Asian country. Du W; Mah JT; Lee J; Sankila R; Sankaranarayanan R; Chia KS Dis Colon Rectum; 2004 Jan; 47(1):78-85. PubMed ID: 14719155 [TBL] [Abstract][Full Text] [Related]
20. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]